Q Fever News and Research

RSS

Scientists engineer antiviral peptide that exploits Achilles' heel of Zika virus

Scientists at Nanyang Technological University, Singapore have engineered an antiviral peptide that exploits the Zika virus at its Achilles' heel - the viral membrane - hence stopping the virus from causing severe infections.

24 Oct 2018

Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics

Some bacterial pathogens, including those that cause strep throat and pneumonia, are able to create the components necessary to replicate their DNA without the usually required metal ions.

19 Oct 2018

A new approach identified to control Zika virus, dengue fever

Mosquitoes are the world's deadliest animals, killing thousands of people and causing millions of illnesses each year.

19 Oct 2018

Cases of Acute Flaccid Myelitis on the rise across U.S.

According to the Centre for Disease Prevention and Control (CDC), cases of dangerous and rare Acute Flaccid Myelitis (AFM) are being noted across United States. This disease manifests similar to acute flaccid paralysis caused by polio virus say the experts. There is at present no treatment for this condition that primarily affects children and leads to paralysis of the limbs.

18 Oct 2018

HIV-infected infants more likely to acquire congenital cytomegalovirus infection

Infants born to HIV-positive mothers had high rates of congenital cytomegalovirus, or CMV. Infants who also were infected before birth by the virus that causes AIDS were especially prone to CMV infection.

16 Oct 2018

WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine

The Walter Reed Army Institute of Research this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.

15 Oct 2018

New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases

Affecting around 2 % of the population, autoimmune rheumatic diseases can have severe symptoms, including painful and swollen joints, fever, rashes, fatigue and sensitivity to the sun, with patients needing regular check-ups.

15 Oct 2018

The impending risk of African Swine Fever Virus

A new emerging pathogen, African Swine Fever Virus (ASFV) has caused outbreaks in 15 countries, including across Europe, and a month ago it was identified in China, the world's largest producer of pork.

15 Oct 2018

Insulin-binding protein in fruit flies could help tackle disease-carrying mosquitos

An insulin-binding protein in fruit flies could provide new opportunities for tackling disease-carrying mosquitos, such as malaria and yellow fever, scientists at the University of York have found.

12 Oct 2018

A new vaccine shows promise in protecting people from rabies, Lassa fever

A novel vaccine designed to protect people from both Lassa fever and rabies showed promise in preclinical testing, according to new research published in Nature Communications.

12 Oct 2018

New vaccine shows effective protection in animal models of Lassa fever

Lassa fever belongs to the same class of hemorrhagic fevers as Ebola. Like Ebola, it has been a major health threat in Western Africa, infecting 100,000-300,000 people and killing 5,000 per year.

11 Oct 2018

DNA vaccine shown to provide long-term protection from Ebola

A synthetic DNA vaccine has been shown to provide complete and enduring protection from Ebola virus in preclinical studies.

11 Oct 2018

New research projects aim to stop spread of African swine fever and prevent outbreak in the U.S.

African swine fever virus threatens to devastate the swine industry and is positioned to spread throughout Asia. The virus has spread throughout the Caucuses region of Eastern Europe and was reported in China in August. It recently was detected in wild boar in Belgium.

10 Oct 2018

Malaria parasites found to be most infectious during mosquito feeding times

Malaria parasites have evolved to be most infectious at the time of day when mosquitoes feed, to maximize the chance of being spread, research shows.

4 Oct 2018

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting glycolate oxidase for the treatment of primary hyperoxaluria type 1.

4 Oct 2018

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

The married professors were spending their Thanksgiving holiday in Egypt when the husband, Thomas L. Patterson, Ph.D., got very sick very quickly, experiencing fever, nausea and a racing heartbeat. By the time Patterson was accurately diagnosed with a highly multi-drug resistant bacterial infection, he was near death.

4 Oct 2018

Special glowing paper strip as rapid, reliable test for infectious diseases

Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

3 Oct 2018

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Genentech, a member of the Roche Group, announced today interim clinical data from the dose-finding parts of the pivotal FIREFISH and SUNFISH studies investigating risdiplam in spinal muscular atrophy.

3 Oct 2018

Penn scientists to explore new approach for predicting and treating diseases at individual level

A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.

3 Oct 2018

Researchers identify genes that could help predict treatment outcomes for parasitic disease

Researchers at the University of York have identified genes in a parasite that could help clinicians predict drug treatment outcomes for patients with visceral leishmaniasis in Brazil.

1 Oct 2018

Q Fever News and Research

Scientists engineer antiviral peptide that exploits Achilles' heel of Zika virus

Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics

A new approach identified to control Zika virus, dengue fever

Cases of Acute Flaccid Myelitis on the rise across U.S.

HIV-infected infants more likely to acquire congenital cytomegalovirus infection

WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine

New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases

The impending risk of African Swine Fever Virus

Insulin-binding protein in fruit flies could help tackle disease-carrying mosquitos

A new vaccine shows promise in protecting people from rabies, Lassa fever

New vaccine shows effective protection in animal models of Lassa fever

DNA vaccine shown to provide long-term protection from Ebola

New research projects aim to stop spread of African swine fever and prevent outbreak in the U.S.

Malaria parasites found to be most infectious during mosquito feeding times

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

Special glowing paper strip as rapid, reliable test for infectious diseases

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Penn scientists to explore new approach for predicting and treating diseases at individual level

Researchers identify genes that could help predict treatment outcomes for parasitic disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News